Orapred Tablet, Orally Disintegrating
Product Images NDC 59212-702

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Orapred (NDC 59212-702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanz Pharma (us) Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg Carton

Orapred ODT is a medication available in orally disintegrating tablets that contain prednisolone sodium phosphate, which is equivalent to 10mg of prednisolone.*

FDA Label Image

15 mg Carton

Orapred ODT is a medication used for certain inflammatory conditions. It is an orally disintegrating tablet that contains prednisolone sodium phosphate, and is equivalent to prednisolone 15mg. The usual dosage should be followed as per the package insert for full prescribing information, and the medication should be stored at 20°- 25°C, (68° - 77°F) away from moisture. The content of the text is, however, incomplete and unclear at some parts.*

FDA Label Image

30 mg Carton

This appears to be a product description for Orapred ODT, an orally disintegrating tablet containing prednisolone sodium phosphate equivalent to 30mg of prednisolone. The package contains 2 cards with only GrapeFlavor containing 6 tablets each. The usual dosage is not specified, but the package insert is recommended for full prescribing information. The tablets should be stored at 20-26°C and protected from moisture.*

FDA Label Image

Chemical Structure For Prednisolone (Orapred Odt 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.